Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CRSP | BMY | AMGN | GILD | VRTX |
Company | Crispr Therapeutics Ag | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 53.98 | 47.39 | 273.45 | 67.47 | 402.44 |
High | 54.15 | 47.50 | 274.35 | 67.90 | 403.88 |
Low | 52.75 | 44.37 | 267.24 | 65.09 | 393.00 |
Last | 53.73 | 44.70 | 269.38 | 65.27 | 397.70 |
Change | -1.92 | -4.16 | -3.63 | -1.81 | -3.06 |
% Change | -3.45% | -8.51% | -1.33% | -2.70% | -0.76% |
Volume | 1,247,839 | 45,041,043 | 1,792,068 | 15,160,858 | 787,526 |
20-Day Average Volume | 1,313,407 | 12,857,282 | 2,149,493 | 6,861,203 | 964,106 |
Previous Close | 55.65 | 48.86 | 273.01 | 67.08 | 400.76 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 60.67 | 49.94 | 270.70 | 68.68 | 402.31 |
20-Day Raw Stochastic | 5.64% | 3.27% | 31.20% | 2.05% | 21.98% |
20-Day Relative Strength | 30.72% | 28.31% | 44.80% | 28.32% | 42.69% |
Weighted Alpha | -15.32 | -34.75 | +9.12 | -23.73 | +14.87 |
Today's Opinion | 24% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
Previous Opinion | 24% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
Last Month's Opinion | 56% Buy | 8% Sell | 24% Buy | 88% Sell | 56% Buy |
Performance | |||||
5-Days | |||||
%Chg | -4.33% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | +1.07% since 04/18/24 |
Low | 52.75 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.25 on 04/19/24 |
High | 58.67 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
1-Month | |||||
%Chg | -24.41% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -4.41% since 03/25/24 |
Low | 52.75 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
High | 73.09 on 03/26/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
3-Month | |||||
%Chg | -14.54% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -7.50% since 01/25/24 |
Low | 52.75 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
High | 91.10 on 02/22/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
6-Month | |||||
%Chg | +37.14% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | +9.55% since 10/25/23 |
Low | 38.16 on 10/30/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 341.90 on 11/16/23 |
High | 91.10 on 02/22/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
Key Statistics | |||||
Market Capitalization, $K | 4,723,740 | 99,027,448 | 146,436,016 | 83,519,768 | 103,580,040 |
Shares Outstanding, K | 84,883 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
Annual Sales | 371,210,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
Annual Net Income | -153,610,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
Last Quarter Sales | 201,210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
Last Quarter Net Income | 89,350,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
60-Month Beta | 1.76 | 0.39 | 0.58 | 0.19 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | 1.10 on 02/21/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
Latest Earnings Date | 05/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 30.13 |